1. Home
  2. HCSG vs RVNC Comparison

HCSG vs RVNC Comparison

Compare HCSG & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCSG
  • RVNC
  • Stock Information
  • Founded
  • HCSG 1976
  • RVNC 1999
  • Country
  • HCSG United States
  • RVNC United States
  • Employees
  • HCSG N/A
  • RVNC N/A
  • Industry
  • HCSG Assisted Living Services
  • RVNC Biotechnology: Pharmaceutical Preparations
  • Sector
  • HCSG Health Care
  • RVNC Health Care
  • Exchange
  • HCSG Nasdaq
  • RVNC Nasdaq
  • Market Cap
  • HCSG N/A
  • RVNC 546.4M
  • IPO Year
  • HCSG N/A
  • RVNC 2014
  • Fundamental
  • Price
  • HCSG $10.45
  • RVNC $5.14
  • Analyst Decision
  • HCSG Buy
  • RVNC Buy
  • Analyst Count
  • HCSG 4
  • RVNC 10
  • Target Price
  • HCSG $14.50
  • RVNC $10.86
  • AVG Volume (30 Days)
  • HCSG 442.1K
  • RVNC 2.6M
  • Earning Date
  • HCSG 10-23-2024
  • RVNC 11-06-2024
  • Dividend Yield
  • HCSG N/A
  • RVNC N/A
  • EPS Growth
  • HCSG N/A
  • RVNC N/A
  • EPS
  • HCSG 0.43
  • RVNC N/A
  • Revenue
  • HCSG $1,684,949,000.00
  • RVNC $251,178,000.00
  • Revenue This Year
  • HCSG $4.64
  • RVNC $20.36
  • Revenue Next Year
  • HCSG $3.14
  • RVNC $31.66
  • P/E Ratio
  • HCSG $23.98
  • RVNC N/A
  • Revenue Growth
  • HCSG 0.61
  • RVNC 40.23
  • 52 Week Low
  • HCSG $8.75
  • RVNC $2.30
  • 52 Week High
  • HCSG $13.00
  • RVNC $9.90
  • Technical
  • Relative Strength Index (RSI)
  • HCSG 48.13
  • RVNC 35.31
  • Support Level
  • HCSG $9.86
  • RVNC $5.13
  • Resistance Level
  • HCSG $10.25
  • RVNC $5.41
  • Average True Range (ATR)
  • HCSG 0.30
  • RVNC 0.19
  • MACD
  • HCSG -0.04
  • RVNC -0.02
  • Stochastic Oscillator
  • HCSG 46.30
  • RVNC 25.49

About RVNC Revance Therapeutics Inc.

Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.

Share on Social Networks: